Skip to main content

Vaccine nationalism? Covaxin isn't safe either, perhaps it's worse: Experts

I was a little awestruck: The news had already spread that Astrazeneca – whose Indian variant Covishield was delivered to nearly 80% of Indian vaccine recipients during the Covid-19 era – has been withdrawn by the manufacturers following the admission by its UK pharma giant that its Covid-19 vector-based vaccine in “rare” instances cause TTS, or “thrombocytopenia thrombosis syndrome”, which lead to the blood to clump and form clots. The vaccine reportedly led to at least 81 deaths in the UK.
As I was one of its crores of Indian recipients – I went so far as to ensure from the nurse at the local urban health centre that it was Covishield, and not the indigenously manufactured Covaxin – my worry was surely natural.
Dr Amitav Banerjee, a renowned Indian epidemiologist, who has served in the armed forces for over two decades and was recently featured on Stanford University’s list of the world’s top 2% scientists, forwarded to me his latest article on the whole controversy. Titled “A To Z Of The AZ-Oxford Doomed Project”, the powerful commentary states that India, sadly, succumbed to the promotion of the vaccine. It says:
“India is a country with a large young population. Around three-fourths (75%) of its population is below 40 years of age. A paper in the Journal of Medical Ethics says administering Covid-19 vaccines to the young is not ethical as it may result in a net harm.
“In a country of over 140 crore people with around 75% of the population below 40 years as a ballpark estimate, we have administered the Covishield vaccine to around 80 crore young Indians who were at least risk from Covid-19 and at higher risk of adverse events.
“Early into the coronavirus pandemic, it was established that the infection-fatality rate of the virus was in the range of 0.00% to 0.05% among people below 70 years, tending towards zero among the youth. Moreover, by the time vaccines were rolled out among the young, serosurveys showed that over 80% of the young had already recovered from natural infection, adding to their robust immunity.
“The great Indian irony is that our policymakers got it right early on. Dr. NK Arora, head of India’s NTAGI (National Technical Advisory Group on Immunisation), wrote an opinion piece on April 12, 2021 in the Times of India, titled, ‘Opening up vaccines for younger adults (18 to 45 years) right now will be a gamble with lives’.
“However, India’s policymakers lost the way as political and commercial pressures piled up.”
This made me ask him the pointed question: Is what has been revealed about Covishield also true of the indigenous Covaxin? His reply was short but precise: “Not sure. Less used and less studied, but what is known is not very reassuring.” I further asked him whether the movie “Vaccine War”, about which he had written, was about Covaxin, and he replied: “Yes, it is about Covaxin.”
Dr Banerjee was quick to forward me with the May 10, 2024 newsletter of the Universal Health Organisation (UHO), whose declared aim is to “bring the updates on the science, battered and bruised during the pandemic, legal updates and impact of activism for a just society, across the world.” While the newsletter is all about Astrazeneca of Covishield, a small section, “Is Covaxin safer than Covishield?”, puts question mark over Bharat Biotech, the indigenous vaccine manufacturers.
Following the Covishield “expose”, Bharat Biotech had already come up a statement claiming that it had taken all the safety measures required for the development of its Covid-19 vaccine. It said, “Covaxin was developed with a single-minded focus on safety first, followed by efficacy… It was the only Covid-19 vaccine in the government's immunisation programme to have conducted efficacy trials in India. It was evaluated in more than 27,000 subjects as part of its licensure process."
“Grabbing” the opportunity to promote Covaxin which contributed less than 20% to the Indian mass vaccination programme, it added, all studies and 'safety follow-up activities' indicated that Covaxin was not associated with “incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis and more".
The UHO newsletter disputes such claim and states: 
“A quick review of the published literature by UHO members is not reassuring and raises concerns about the safety of this (Covaxin) vaccine as well. A peer reviewed paper published in Indian Heart Journal reported that both Covishield and Covaxin were associated with serious thromboembolic (clotting) events.
“Besides there are a number of scattered reports of instances of serious side effects from Covaxin ranging from myocarditis (inflammation of heart muscle), deep vein thrombosis affecting the brain to central retinal artery occlusion (leading to blindness), aggravation of psoriasis, among others.”

While I am no expert of the subject, the fact is, the Indian Heart Journal paper strongly suggests that Covaxin is even more dangerous than Covishield. Let me quote from it, “There were higher rates of DVT/PE after Covaxin administration (4/13, 31%) compared to Covishield (2/35, 5%, p¼0.04).” The “small study” has been interpreted to point out that it “showed there were higher rates of DVT/PE (both clotting issues) after Covaxin administration compared to Covishield.”
This comes amidst strong efforts to link Covaxin with the new variety of nationalism sought to be promoted after Narendra Modi came to power in 2014. The maker of hyper-nationalistic films with clear anti-minority bias, Vivek Agnihotri, “Kashmir Files” and “Kerala Story”, recently released “Vaccine War” in order to justify and propagate the great work done by coming up with the indigenous Covid-19 vaccine.
While I have not seen the film, Counterview published three articles which partially or fully review “Vaccine War”. One of them is by Dr Banerjee, who says, with this film, “science seems to be venturing into the glamorous Bollywood arena! Serious science can take a backseat! Glamour and glitz can serve as the fast food for the public imagination.”
Another by Bhaskaran Raman, who is Professor at the Indian Institute of Technology Bombay, insists, “The movie is problematic right in its name. A person gets to be called a doctor only after successfully passing her medical degree. Likewise, a product gets to be called as a vaccine only after successful completion of trials.”
“However”, Raman continues, “There is no completed trial data for any of the Covid-19 vaccine candidates: for the products used in India or anywhere else in the world. Therefore the term 'vaccine' for the experimental Covid-19 injections is an achievement of propaganda, not of science. The movie serves to further this propaganda.”
He concludes, “There are several crowning achievements of Indian scientists over the ages, which Indians can be rightfully proud of: ranging from zero (literally) to Ramanujam’s breathtaking mathematical genius to the recent strides in rocket science (also literal). Covid-19 vaccine development and rollout is most emphatically not among them.”
And finally, titled “Plenty of 'unwarranted fear mongering' about Covid virus, pandemic in The Vaccine War”, a person who has written in his (or her?) pseudonym, says, “The focus of the movie is on India’s indigenously developed vaccine Covaxin. Covaxin is a whole inactivated virus-based Covid-19 vaccine. The film promotes what could be called ‘vaccine nationalism’, or, in simplified terms: foreign vaccines bad, indigenous vaccines good.” Thus, there is “selective pro-vaccine propaganda” which “makes the movie a limited hangout.”
Disputing the indigenous claim, it underlines, “Bharat Biotech, the company where Covaxin was developed, was heavily funded by the Bill & Melinda Gates Foundation (BMGF) and the international pharma lobby, making its indigenous credentials somehow suspect.” 
Yet, ironically, the film attacks a journalist named Rohini Singh Dhulla: “She is shown as a complete lackey and tool of the ‘foreign’ pharma lobby and of Pfizer, who is continuously attacking (Indian) ... vaccine scientists.” Thus, it “ignores or downplays dissenting views.”

Comments

TRENDING

Dalit rights and political tensions: Why is Mevani at odds with Congress leadership?

While I have known Jignesh Mevani, one of the dozen-odd Congress MLAs from Gujarat, ever since my Gandhinagar days—when he was a young activist aligned with well-known human rights lawyer Mukul Sinha’s organisation, Jan Sangharsh Manch—he became famous following the July 2016 Una Dalit atrocity, in which seven members of a family were brutally assaulted by self-proclaimed cow vigilantes while skinning a dead cow, a traditional occupation among Dalits.  

Powering pollution, heating homes: Why are Delhi residents opposing incineration-based waste management

While going through the 50-odd-page report Burning Waste, Warming Cities? Waste-to-Energy (WTE) Incineration and Urban Heat in Delhi , authored by Chythenyen Devika Kulasekaran of the well-known advocacy group Centre for Financial Accountability, I came across a reference to Sukhdev Vihar — a place where I lived for almost a decade before moving to Moscow in 1986 as the foreign correspondent of the daily Patriot and weekly Link .

Boeing 787 under scrutiny again after Ahmedabad crash: Whistleblower warnings resurface

A heart-wrenching tragedy has taken place in Ahmedabad. As widely reported, a Boeing 787 Dreamliner plane crashed shortly after taking off from the city’s airport, currently operated by India’s top tycoon, Gautam Adani. The aircraft was carrying 230 passengers and 12 crew members.  As expected, the crash has led to an outpouring of grief across the country. At the same time, there have been demands for the resignation of Prime Minister Narendra Modi, Home Minister Amit Shah, and the Civil Aviation Minister.

Ahmedabad's civic chaos: Drainage woes, waterlogging, and the illusion of Olympic dreams

In response to my blog on overflowing gutter lines at several spots in Ahmedabad's Vejalpur, a heavily populated area, a close acquaintance informed me that it's not just the middle-class housing societies that are affected by the nuisance. Preeti Das, who lives in a posh locality in what is fashionably called the SoBo area, tells me, "Things are worse in our society, Applewood."

Global NGO slams India for media clampdown during conflict, downplays Pakistan

A global civil rights group, Civicus has taken strong exception to how critical commentaries during the “recent conflict” with Pakistan were censored in India, with journalists getting “targeted”. I have no quarrel with the Civicus view, as the facts mentioned in it are all true.

Remembering Vijay Rupani: A quiet BJP leader who listened beyond party lines

Late evening on June 12, a senior sociologist of Indian origin, who lives in Vienna, asked me a pointed question: Of the 241 persons who died as a result of the devastating plane crash in Ahmedabad the other day, did I know anyone? I had no hesitation in telling her: former Gujarat chief minister Vijay Rupani, whom I described to her as "one of the more sensible persons in the BJP leadership."

Whither SCOPE? Twelve years on, Gujarat’s official English remains frozen in time

While writing my previous blog on how and why Narendra Modi went out of his way to promote English when he was Gujarat chief minister — despite opposition from people in the Sangh Parivar — I came across an interesting write-up by Aakar Patel, a well-known name among journalists and civil society circles.

A conman, a demolition man: How 'prominent' scribes are defending Pritish Nandy

How to defend Pritish Nandy? That’s the big question some of his so-called fans seem to ponder, especially amidst sharp criticism of his alleged insensitivity during his journalistic career. One such incident involved the theft and publication of the birth certificate of Masaba Gupta, daughter of actor Neena Gupta, in the Illustrated Weekly of India, which Nandy was editing at the time. He reportedly did this to uncover the identity of Masaba’s father.

Why India’s renewable energy sector struggles under 2,735 compliance hurdles

Recently, during a conversation with an industry representative, I was told how easy it is to set up a startup in Singapore compared to India. This gentleman, who had recently visited Singapore, explained that one of the key reasons Indians living in the Southeast Asian nation prefer establishing startups there is because the government is “extremely supportive” when it comes to obtaining clearances. “They don’t want to shift operations to India due to the large number of bureaucratic hurdles,” he remarked.